Friedländer annulation: scope and limitations of metal salt Lewis acid catalysts in selectivity control for the synthesis of functionalised quinolines
作者:Babita Tanwar、Dinesh Kumar、Asim Kumar、Md. Imam Ansari、Mohammad Mohsin Qadri、Maulikkumar D. Vaja、Madhulika Singh、Asit K. Chakraborti
DOI:10.1039/c5nj02010g
日期:——
products during the reaction involving 2-aminobenzophenone and ethyl acetoacetate. Among a pool of metal halides, tetrafluoroborates, perchlorates, and triflates used as catalysts, In(OTf)3 emerged as the most effective catalyst for the selective/exclusive formation of the Friedländer product. The generality of the In(OTf)3-catalysed Friedländer reaction was demonstrated by the reaction of differently substituted
Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads
作者:Babita Tanwar、Asim Kumar、Perumal Yogeeswari、Dharmarajan Sriram、Asit K. Chakraborti
DOI:10.1016/j.bmcl.2016.10.082
日期:2016.12
Two series of quinoline-based compounds were designed, synthesised and evaluated for anti-tubercular activity against Mycobacterium tuberculosis H(37)Rv (ATCC 27294 strain). A new method for Friedlander quinoline synthesis has been developed in water under the catalytic influence of the Bronsted acid surfactant DBSA. Among the forty-two compounds tested for anti-TB activity, twenty-three compounds exhibited significant activity against the growth of M. tuberculosis (MIC 0.02-6.25 mu g/mL). In particular, the compounds 3b and 3c displayed excellent anti-TB activity with MIC values of 0.2 and 0.39 mu g/mL, respectively, and are more potent than the standard drugs E, Cfx and Z that are clinically used to treat TB. The cytotoxicity of the compounds with MIC <= 6.25 mu g/mL was evaluated against Human Embryonic Kidney 293T cell lines and all of the active compounds were found to be nontoxic (<50% inhibition). The results suggest that the synthesised substituted quinolines are promising leads for development of new drug to treat TB. (C) 2016 Elsevier Ltd. All rights reserved.